✦ LIBER ✦

4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study

✍ Scribed by Angelo M. Carella; Gino Santini; Marina Martinengo; Domenico Giordano; Sandro Nati; Angela Congiu; Raffaella Cerri; Marco Risso; Eugenio Damasio; Edoardo Rossi; Renato Vimercati; Maria A. Pacciarini; Alberto M. Marmont

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 268 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850401)55:7<1452::aid-cncr2820550705>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Idarubicin, cytarabine, and topotecan in

Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome

✍ Seung Tae Lee; Joon Ho Jang; Hyung Chan Suh; Jee Sook Hahn; Yun Woong Ko; Yoo Ho 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Phase 2 randomized study of p53 antisens

Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia

✍ Jorge Cortes; Hagop Kantarjian; Edward D. Ball; John DiPersio; Jonathan E. Kolit 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Arsenic trioxide- and idarubicin-induced

Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: Clinicopathological and molecular features of a pilot study

✍ Y.L. Kwong; W.Y. Au; C.S. Chim; A. Pang; C. Suen; R. Liang 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Mitoxantrone, etoposide, and cytarabine

Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia : An Eastern Cooperative Oncology Group pilot study

✍ Martin S. Tallman; Sandra Lee; Branimir I. Sikic; Elisabeth Paietta; Peter H. Wi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Background: One potential mechanism of drug resistance to chemotherapy is the overexpression of multidrug resistance (mdr) genes coding for p-glycoprotein (p-gp), which leads to reduced intracellular retention of chemotherapy. this study tested the efficacy and toxicity of mitoxantrone, etoposid

Phase 1 multicenter study of vincristine

Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia

✍ Deborah A. Thomas; Hagop M. Kantarjian; Wendy Stock; Leonard T. Heffner; Stefan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

Mitoxantrone and 5-azacytidine for refra

Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: A leukemia intergroup study

✍ Jack Goldberg; Jeff Gryn; Azra Raza; John Bennett; George Browman; John Bryant; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 1 views

In an effort to determine if cell cycle active agents are augmented when given after non-cell cycle active agents, 104 patients with either multiply relapsed or refractory acute nonlymphocytic leukemia or blast crisis of chronic myelogenous leukemia were treated with mitoxantrone. Patients whose bon